This analysis only revealed statistically significant differences in two NK cells populations (pop 6 and pop 12) that were reduced in AML patients (Pop 6: PD-1+ TIM3+ CD8+ , p = 0.0011 and Pop12: TIM3+ , p = 0.0463). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.